Guidance is available from expert consensus groups and regulatory agencies to assist with integrating genetic information into P2Y12 inhibitor prescribing decisions, and CYP2C19 genotype‐guided antiplatelet therapy after PCI is one of the most common examples of clinical pharmacogenetic implementation. Herein...
but not activate the receptor. Germane to our study is a report concerning a patient with chronic bleeding that had a homozygous R122C substitution within the DRY motif of P2Y12 [17]. There are also several examples of heterozygous and homozygous mutations that result in either reduced or absen...